Logo image of GPRE

GREEN PLAINS INC (GPRE) Stock Fundamental Analysis

USA - NASDAQ:GPRE - US3932221043 - Common Stock

9.37 USD
-0.28 (-2.9%)
Last: 9/22/2025, 8:28:22 PM
9.6 USD
+0.23 (+2.45%)
After Hours: 9/22/2025, 8:28:22 PM
Fundamental Rating

2

GPRE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of GPRE have multiple concerns. GPRE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GPRE has reported negative net income.
In the past year GPRE had a positive cash flow from operations.
GPRE had negative earnings in each of the past 5 years.
Of the past 5 years GPRE 4 years had a positive operating cash flow.
GPRE Yearly Net Income VS EBIT VS OCF VS FCFGPRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

With a Return On Assets value of -9.42%, GPRE is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
GPRE has a worse Return On Equity (-20.66%) than 79.52% of its industry peers.
Industry RankSector Rank
ROA -9.42%
ROE -20.66%
ROIC N/A
ROA(3y)-5.15%
ROA(5y)-5.08%
ROE(3y)-11.53%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
GPRE Yearly ROA, ROE, ROICGPRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

GPRE's Gross Margin of 5.50% is on the low side compared to the rest of the industry. GPRE is outperformed by 74.76% of its industry peers.
GPRE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for GPRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.46%
GM growth 5Y30.95%
GPRE Yearly Profit, Operating, Gross MarginsGPRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

More info and screens

2

2. Health

2.1 Basic Checks

GPRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GPRE has more shares outstanding
The number of shares outstanding for GPRE has been increased compared to 5 years ago.
Compared to 1 year ago, GPRE has a worse debt to assets ratio.
GPRE Yearly Shares OutstandingGPRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GPRE Yearly Total Debt VS Total AssetsGPRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

GPRE has an Altman-Z score of 1.47. This is a bad value and indicates that GPRE is not financially healthy and even has some risk of bankruptcy.
GPRE has a Altman-Z score (1.47) which is comparable to the rest of the industry.
GPRE has a Debt/Equity ratio of 0.74. This is a neutral value indicating GPRE is somewhat dependend on debt financing.
GPRE has a Debt to Equity ratio of 0.74. This is in the lower half of the industry: GPRE underperforms 61.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACCN/A
WACC8.18%
GPRE Yearly LT Debt VS Equity VS FCFGPRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

GPRE has a Current Ratio of 1.47. This is a normal value and indicates that GPRE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of GPRE (1.47) is better than 66.67% of its industry peers.
A Quick Ratio of 0.94 indicates that GPRE may have some problems paying its short term obligations.
GPRE has a Quick ratio of 0.94. This is comparable to the rest of the industry: GPRE outperforms 50.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.94
GPRE Yearly Current Assets VS Current LiabilitesGPRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

GPRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -145.83%.
GPRE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.03%.
Measured over the past years, GPRE shows a small growth in Revenue. The Revenue has been growing by 0.34% on average per year.
EPS 1Y (TTM)-145.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.05%
Revenue 1Y (TTM)-15.03%
Revenue growth 3Y-4.55%
Revenue growth 5Y0.34%
Sales Q2Q%-10.66%

3.2 Future

Based on estimates for the next years, GPRE will show a very strong growth in Earnings Per Share. The EPS will grow by 57.49% on average per year.
Based on estimates for the next years, GPRE will show a quite strong growth in Revenue. The Revenue will grow by 8.70% on average per year.
EPS Next Y-81.95%
EPS Next 2Y35.28%
EPS Next 3Y33.47%
EPS Next 5Y57.49%
Revenue Next Year-7.87%
Revenue Next 2Y-5.19%
Revenue Next 3Y8.67%
Revenue Next 5Y8.7%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GPRE Yearly Revenue VS EstimatesGPRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
GPRE Yearly EPS VS EstimatesGPRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GPRE. In the last year negative earnings were reported.
Also next year GPRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GPRE Price Earnings VS Forward Price EarningsGPRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GPRE is valued a bit more expensive than the industry average as 70.48% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 40.9
GPRE Per share dataGPRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as GPRE's earnings are expected to grow with 33.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.28%
EPS Next 3Y33.47%

More info and screens

0

5. Dividend

5.1 Amount

GPRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREEN PLAINS INC

NASDAQ:GPRE (9/22/2025, 8:28:22 PM)

After market: 9.6 +0.23 (+2.45%)

9.37

-0.28 (-2.9%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-11 2025-08-11/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners92.18%
Inst Owner Change2.22%
Ins Owners1.34%
Ins Owner Change4.49%
Market Cap640.63M
Analysts73.33
Price Target10.09 (7.68%)
Short Float %13.37%
Short Ratio4.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)-36.76%
DP-3.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-74.79%
Min EPS beat(2)-101.38%
Max EPS beat(2)-48.21%
EPS beat(4)1
Avg EPS beat(4)11.96%
Min EPS beat(4)-165.14%
Max EPS beat(4)362.54%
EPS beat(8)2
Avg EPS beat(8)4.48%
EPS beat(12)2
Avg EPS beat(12)-764.98%
EPS beat(16)3
Avg EPS beat(16)-603.96%
Revenue beat(2)0
Avg Revenue beat(2)-7.62%
Min Revenue beat(2)-12.91%
Max Revenue beat(2)-2.34%
Revenue beat(4)0
Avg Revenue beat(4)-6.95%
Min Revenue beat(4)-12.91%
Max Revenue beat(4)-2.34%
Revenue beat(8)1
Avg Revenue beat(8)-5.95%
Revenue beat(12)4
Avg Revenue beat(12)-3.54%
Revenue beat(16)8
Avg Revenue beat(16)-0.87%
PT rev (1m)3.41%
PT rev (3m)14.65%
EPS NQ rev (1m)44.77%
EPS NQ rev (3m)-262.97%
EPS NY rev (1m)0%
EPS NY rev (3m)-133.04%
Revenue NQ rev (1m)7.21%
Revenue NQ rev (3m)-6.51%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF 16.22
P/B 0.87
P/tB 0.87
EV/EBITDA 40.9
EPS(TTM)-1.77
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)0.58
OCFY6.17%
SpS35.06
BVpS10.75
TBVpS10.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.42%
ROE -20.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.5%
FCFM N/A
ROA(3y)-5.15%
ROA(5y)-5.08%
ROE(3y)-11.53%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.46%
GM growth 5Y30.95%
F-Score3
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF N/A
Debt/EBITDA 23.14
Cap/Depr 85.63%
Cap/Sales 3.48%
Interest Coverage N/A
Cash Conversion 168.3%
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.94
Altman-Z 1.47
F-Score3
WACC8.18%
ROIC/WACCN/A
Cap/Depr(3y)148.04%
Cap/Depr(5y)157.81%
Cap/Sales(3y)4.32%
Cap/Sales(5y)5.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.05%
EPS Next Y-81.95%
EPS Next 2Y35.28%
EPS Next 3Y33.47%
EPS Next 5Y57.49%
Revenue 1Y (TTM)-15.03%
Revenue growth 3Y-4.55%
Revenue growth 5Y0.34%
Sales Q2Q%-10.66%
Revenue Next Year-7.87%
Revenue Next 2Y-5.19%
Revenue Next 3Y8.67%
Revenue Next 5Y8.7%
EBIT growth 1Y-143.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year158.11%
EBIT Next 3Y72.08%
EBIT Next 5Y72%
FCF growth 1Y64.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y400.08%
OCF growth 3YN/A
OCF growth 5YN/A